Qube Research & Technologies Ltd

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,604,889

-$2,284,861 QoQ

Shares Held

794,542

-7.6% QoQ

Ownership

0.767%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#39

of 179 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. ORIC ranks #51 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,604,889	794,542	-7.6%	Shares	Sole	2026-08-14
2026-03-31	$10,889,750	859,491	-28.7%	Shares	Sole	2026-05-15
2025-12-31	$9,860,409	1,205,429	+1384.0%	Shares	Sole	2026-02-17
2024-06-30	$574,274	81,227	+53.1%	Shares	Sole	2024-08-14
2024-03-31	$729,341	53,043	-21.4%	Shares	Sole	2024-05-14
2023-03-31	$384,556	67,466	+70.0%	Shares	Sole	2023-05-15
2022-12-31	$233,762	39,688	+54.7%	Shares	Sole	2023-02-14
2022-09-30	$82,112	25,660	-17.4%	Shares	Sole	2022-11-14
2022-06-30	$139,117	31,053	+37.9%	Shares	Sole	2022-08-15
2021-06-30	$398,237	22,512	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.